![](https://investorshub.advfn.com/uicon/315468.png?cb=1473363790)
Tuesday, June 20, 2017 1:05:45 PM
Pharmaceutical companies publish their research in peer reviewed Journals from pre-clinical trials and as they progress through each stage of the trials.
How in the hell is releasing the efficacy report going to undermine the IP - that is deflection and defending the OWCP scam.
Take a look at all of the scientific publications that GW Pharmaceuticals release every year.
The problem is too many people invested in OWCP thinking they owned 7 patents - which isn't close to being truthful.
Are you suggesting that that patent applications (which were all rejected) isn't enough protection?
The information from the company is smoke and mirrors - at it's comical best.
"Read the 8-K released on April 4th. "...The Company actively protects its IP and will release the final results, relevant protocols and clinical data after the completion of the full BIO-DATA IP PROTECTION....""
This is so the OWCP scammers can keep dangling the carrots in front of investors.
IG
"Straight Facts Homey!"
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM